New Insights Into the Comorbidity of Coronary Heart Disease and Depression

Area of Science:

• Cardiology
• Psychiatry
• Medical Research

Background:

• Coronary heart disease (CHD) and depression are prevalent conditions impacting quality of life and healthcare costs.
• The frequent co-occurrence of CHD and depression suggests underlying shared pathological mechanisms.
• This comorbidity exacerbates patient conditions and worsens prognosis.

Purpose of the Study:

• To review the incidence of depression in CHD patients.
• To examine the adverse effects of depression on CHD symptoms.
• To explore potential shared pathological mechanisms, including novel factors like endocrine substances, gut microbiome, and microRNA.

Main Methods:

• Literature review focusing on the comorbidity of CHD and depression.
• Synthesis of existing knowledge on shared mechanisms.
• Inclusion of recent findings on novel contributing factors.

Main Results:

• Depression is common in CHD patients and negatively impacts CHD symptoms.
• Established mechanisms contributing to the comorbidity are well-documented.
• Emerging evidence points to endocrine substances, gut microbiome, and microRNA as novel potential mechanisms.

Conclusions:

• The comorbidity of CHD and depression necessitates understanding shared mechanisms.
• Novel factors like the gut microbiome and microRNA offer new avenues for research.
• Integrated treatment strategies involving pharmacotherapy and psychotherapy are crucial for managing this dual diagnosis.